Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5141]

Advanced Prostate Cancer - The evolving landscape and targeted therapies

Prof Nicholas Mottet, Prof Amit Bahl, Prof Piet Ost and Dr Inge Van Oort

Advanced Prostate Cancer - The evolving landscape and targeted therapies ( Prof Nicholas Mottet, Prof Amit Bahl, Prof Piet Ost and Dr Inge Van Oort )

Highlights from PROSCA 2018: Imaging, biomarkers and genetic testing

Prof Noel Clarke, Prof Hardev Pandha, Prof Amit Bahl and Dr Nina Tunariu

Highlights from PROSCA 2018: Imaging, biomarkers and genetic testing ( Prof Noel Clarke, Prof Hardev Pandha, Prof Amit Bahl and Dr Nina Tunariu )

Expert insight: The basic medical understanding of neutropenia and general...

Dr Matti Aapro - Genolier Cancer Center, Genolier, Switzerland

Expert insight: The basic medical understanding of neutropenia and general clinical considerations ( Dr Matti Aapro - Genolier Cancer Center, Genolier, Switzerland )

MASCC 2018: Chemotherapy-induced neutropenia and the role of G-CSFs

Prof Jean Klastersky and Prof Bernardo Rapoport

MASCC 2018: Chemotherapy-induced neutropenia and the role of G-CSFs ( Prof Jean Klastersky and Prof Bernardo Rapoport )

CDK6 a transcriptional regulator in AML

Prof Veronika Sexl - University of Veterinary Medicine of Vienna, Vienna...

CDK6 a transcriptional regulator in AML ( Prof Veronika Sexl - University of Veterinary Medicine of Vienna, Vienna, Austria )

ASCO 2018 conference round up

Dr Bishal Gyawali and Will Davies

ASCO 2018 conference round up ( Dr Bishal Gyawali and Will Davies )

Treating CLL with obinutuzumab

Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany

Treating CLL with obinutuzumab ( Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany )

Half of CLL patients who relapse on ibrutinib harbour BTK/PLCG mutations

Dr Lydia Scarfo - San Raffaele Scientific Institute, Milan, Italy

Half of CLL patients who relapse on ibrutinib harbour BTK/PLCG mutations ( Dr Lydia Scarfo - San Raffaele Scientific Institute, Milan, Italy )

First in-human trial of AMV564 for AML

Prof Peter Westervelt - Washington University School of Medicine, St Louis, USA

First in-human trial of AMV564 for AML ( Prof Peter Westervelt - Washington University School of Medicine, St Louis, USA )

SETBP1 induces transcription of developmental genes

Dr Rocco Piazza - University of Milano-Bicocca, Milan, Italy

SETBP1 induces transcription of developmental genes ( Dr Rocco Piazza - University of Milano-Bicocca, Milan, Italy )

Combination therapy for CLL in the CAPTIVATE trial

Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy

Combination therapy for CLL in the CAPTIVATE trial ( Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy )

Efficacy of novel agents in r/r T pro-lymphocytic leukaemia

Prof Philipp Staber - Medical University of Vienna, Vienna, Austria

Efficacy of novel agents in r/r T pro-lymphocytic leukaemia ( Prof Philipp Staber - Medical University of Vienna, Vienna, Austria )

More from ecancer